MPM is a cancer that targets the lung pleura, or lining of the lungs. Serous membranes surround the lungs, and mesothelioma is a variety of cancer that swarms those membranes. Other serous membranes can be affected as well including those surrounding the abdomen and heart. The phrase lung cancer applies precisely to cancers that are born in the lungs.

One contrast separating asbestosis and peritoneal mesothelioma in that the latter is cancer and the former is not. Asbestosis originates in the lungs and is brought about by inhaling asbestos fibers that come to be embedded in the pleura. Malignant pleural mesothelioma cancer accounts for roughly 75% of all mesothelioma cases.

Chest discomfort and shortness of breath are regular symptoms, but the pain can emerge in other regions of the body.The discovery often occurs when the growing tumors enlarge the pleural area, bringing about pain as it fills with fluid. This is called pleural effusion.

Getting Tested

The standard work-up for a person suspected of mesothelioma cancer includes noninvasive lab tests, serum tumor markers, X-rays, and computed tomography (CT) scans of the appropriate regions. Markers are substances usually located in the blood or urine that present themselves as reactions to cancer cells. The presence, transformation, and variation in quantity of these substances are assessed to assist in the recognition of cancer and evaluation of cancer treatments. Over 80 percent of all cases of MPM will display an enlarged pleural area in chest X-rays.

Pulmonary function tests are employed to assess the ability of the lungs to inhale, release, and transfer oxygen into the blood. Patients with MPM regularly show restrictive breathing patterns and reduced oxygen transfer.

Expeditious and accurate diagnosis of malignant pleural mesothelioma is critical in order to draw a distinction between it and adenocarcinoma, a cancer that originates in tissues of the glands. In some instances , a sample must be drawn out by fine needle removal from the tumor, especially if there is no apparent effusion.

A CT-scan provides additional contrast and sensitivity to uncover the existence of pleural expansion, tumors, enlargement of the lymph nodes, and confirmation of asbestos exposure. If surgery is under review, magnetic resonance imaging can assess the extent of the tumor within areas such as the diaphragm and ribs. It can , in addition, assist in the planning and execution of localized radiotherapy.

Recent Advances

Positron emission tomography is an imaging technique to spot chest involvement and migration of the cancerous cells to other parts of the body. PET is nuclear-based and uses small amounts of radioactive material to assist the diagnosis and treatment, and has the capability to differentiate malignant pleural masses from benign masses.

In the case that noninvasive tests are not conclusive, thoracoscopy is valuable in assessing the nature and extent of pleural and lung lesions. It can be used to aid in surgical operations as well as visualization of the impacted area. Referred to as VATS, video-assisted thoracoscopic surgery assumes a small probability of dispersing a tumor along the incisions and chest tube tracts. Invasive exams such as colonoscopy and endoscopy are sometimes needed to expel colon and stomach cancer.